SECTORS TODAY
Tech XLK -4.89%
Financials XLF -0.76%
Healthcare XLV +0.45%
Energy XLE +1.91%
Industrials XLI -1.60%
Cons. Disc. XLY -0.71%
Cons. Staples XLP +1.41%
Utilities XLU +0.67%
Materials XLB +0.40%
Real Estate XLRE +0.26%
Comm. Svcs XLC -1.29%

Earnings release · ISRG

INTUITIVE ANNOUNCES THIRD QUARTER EARNINGS

Intuitive Surgical Inc. · Filed · SEC Form 8-K, Item 2.02

Intuitive Surgical company page Original on SEC.gov ↗

Revenue $3.05 billion +22% vs a year ago
EPS $0.99 not detected
Guidance issuedoutlook statement
Automated extract. The items below were picked out of the company's press release by software and may be wrong or incomplete. Please read the original before relying on any figure. Not investment advice.

Why it matters

Revenue increased 22% year on year to $3.05 billion, and EPS was $0.99. The company issued new guidance, which gives a first marker for expectations in the periods ahead.

Written automatically by Stocknote's note engine from the figures on this page and the company's previous release. Every number in this note is checked against those figures. Not investment advice.

What the company states

Revenue

$3.05 billion +22% vs a year ago

…Third quarter 2026 revenue of $3.05 billion increased 22%, compared with $2.51 billion in the third quarter of 2025.…
EPS

$0.99

…The third quarter 2026 expense was $347 million, net of tax, or $0.99 per diluted share.…
Guidance

Guidance issued

…We do not provide a reconciliation of non-GAAP outlook measures to corresponding GAAP measures on a forward-looking basis, because we are unable to predict with reasonable certainty the exact timing and ultimate outcome of c…

Read the original press release on SEC.gov ↗ Filing index ↗

Our research on ISRG

Company page →
Disclaimer: This page is generated automatically from public SEC filings for information only. Stocknote does not edit the company's release and does not guarantee the accuracy of the extracted items. Read the full disclaimer here.

Get new research in your inbox

Forensic equity research on US stocks. No spam, unsubscribe anytime.